organ testing

R&D

Researchers are beginning to imagine a future in which development pipelines are more predictive, more efficient, and ultimately more humane.

News

Ipsen has agreed to buy cancer biotech Kartos Therapeutics for $450m upfront, adding a late-stage drug in the challenging MDM2 inhibitor class.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.